Yale Study Finds Injectable Hydrogel Relieves Osteoarthritis Pain and Repairs Cartilage
A recent study conducted by Yale researchers, published in the journal Bioactive Materials, has discovered a promising treatment for osteoarthritis using an injectable hydrogel. The study highlights the effectiveness of lacosamide, a medication traditionally used for epilepsy, in relieving joint pain and reversing cartilage damage when delivered directly into the joint via a specialized hydrogel. Osteoarthritis, a condition characterized by the deterioration of cartilage, leads to pain and stiffness in affected joints. Current treatments often focus on pain relief without addressing the underlying cartilage damage. The study, led by Chuan-Ju Liu, Ph.D., emphasizes the dual-purpose nature of the Nav1.7 protein, which influences both pain perception and tissue health. By targeting this protein, lacosamide can potentially reduce pain and promote cartilage repair. The hydrogel delivery system ensures the medication remains concentrated in the joint, providing long-lasting relief without the need for daily oral... 
